Monoclonal Lym-1 antibody-dependent cytolysis by neutrophils exposed to granulocyte-macrophage colony-stimulating factor: Intervention of FcγR(II) (CD32), CD11b-CD18 integrins, and CD66b glycoproteins

Blood

Volumn 93, Issue 10, 1999, Pages 3505-3511

  Ottonello, L ^b   Epstein, A L ^b   Dapino, P ^b   Barbera, P ^b   Morone, P ^b   Dallegri, Franco ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; FC RECEPTOR; GLYCOPROTEIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN G2A; INTEGRIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY LYM 1; UNCLASSIFIED DRUG;

ARTICLE; CELL SURFACE; CROSS LINKING; CYTOLYSIS; EFFECTOR CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; NEUTROPHIL; PHAGOCYTE; PRIORITY JOURNAL; PROTEIN INTERACTION; RAJI CELL;

EID: 0033562365     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.10.3505.410k20_3505_3511     Document Type: Article

References (30)

1. Hu E, Epstein AL, Naeve GS, Gill I, Martin S, Sherrod A, Nichols P, Chen D, Mazumder A, Levine AM: A phase 1a clinical trial of Lym-1 monoclonal antibody serotherapy in patients with refractory B cell malignancies. Hematol Oncol 7:155, 1989
2. Grossbard ML, Press OW, Appelbaum FR, Bernstein ID, Nadler LM: Monoclonal antibody-based therapies of leukemia and lymphoma. Blood 80:863, 1992
3. Epstein AL, Mader RJ, Winter JN, Stathopoulos E, Chen FM, Parker JW, Taylor CR: Two new monoclonal antibodies, Lym-1 and Lym-2, reactive with human B-lymphocytes and derived tumors, with immunodiagnostic and immunotherapeutic potential. Cancer Res 47: 830, 1987
4. Epstein AL, Zimmer AM, Spies SM: Radioimmunodetection of human B-cell lymphomas with a radiolabeled tumor specific monoclonal antibody, Lym-1, in Cavalli F, Bonadonna G, Rozencweig M (eds): Malignant Lymphomas and Hodgkin Disease: Experimental and Therapeutic Advances. Boston, MA, Martinus Nijhoff, 1985, p 569
5. Gill I, Agah R, Hu E, Mazumder A: Synergistic antitumor effects of interleukin 2 and the monoclonal Lym-1 against human Burkitt lymphoma cells in vitro and in vivo. Cancer Res 49:5377, 1989
6. Biddle WC, Pancook J, Goldrosen M, Han T, Foon KA, Vaickus L: Antibody-dependent, cell-mediated cytotoxicity by an anti-class II murine monoclonal antibody: Effect of recombinant interleukin-2 on human effector cell lysis of human B-cell tumors. Cancer Res 50:2991, 1990
7. Vaickus L, Biddle W, Cemerlic D, Foon KA: Interferon gamma augments Lym-1-dependent, granulocyte-mediated tumor cell lysis. Blood 75:2408, 1990
8. Cemerlic D, Dadey B, Han T, Vaickus L: Cytokine influence on killing of fresh chronic lymphocytic leukemia cells by human leukocytes. Blood 77:2707, 1991
9. Ottonello L, Morone P, Dapino P, Dallegri F: Monoclonal Lym-1 antibody-dependent lysis of B-lymphoblastoid tumor targets by human complement and cytokine-exposed mononuclear and neutrophilic polymorphonuclear leukocytes. Blood 87:5171, 1996
10. Golde DW, Baldwin GC: Myeloid growth factors, in Gallin JI, Goldstein IM, Suyderman R (eds): Inflammation: Basic Principles and Clinical Correlates. New York, NY, Raven, 1992, p 291
11. Brach MA, de Vos S, Gruss HJ, Herrmann F: Prolongation of survival of human polymorphonuclear neutrophils by granulocyte-macrophage colony-stimulating factor is caused by inhibition of programmed cell death. Blood 80:2920, 1992
12. Ragnhammar P, Fagerberg J, Frodin JE, Hjelm AL, Lindemalm C, Magnusson I, Masucci G, Mellstedt H: Effect of monoclonal antibody 17-1A and GM-CSF in patients with advanced colorectal carcinoma long-lasting, complete remission can be induced. Int J Cancer 53:751, 1993
13. Kushner BH, Cheung NV: Absolute requirement of CD11/CD18 adhesion molecules, FcRII, and the phosphatidylinositol-linked FcRIII for monoclonal antibody-mediated neutrophil antihuman tumor cytoxicity. Blood 79:1484, 1992
14. Stocks SC, Rucaud-Sparagano MH, Kerr MA, Grunert F, Haslett C, Dransfield I: CD66: Role in the regulation of neutrophil effector function. Eur J Immunol 26:2924, 1996
15. Skubitz KM, Campbell KD, Skubitz APN: CD66a, CD66b, and CD66d each independently stimulate neutrophils. J Leukoc Biol 60:106, 1996
16. γ receptor III on human neutrophils. J Immunol 150:3030, 1993
17. Xue W, Kindzelskii AL, Todd RF III, Petty HR: Physical association of complement receptor type 3 and urokinase-type plasminogen activator receptor in neutrophil membrane. J Immunol 152:4630, 1994
18. Todd RF III, Petty HR: β2(CD11/CD18) integrins can serve as signaling partners for other leukocyte receptors. J Lab Clin Med 129:492, 1997
19. Stöckl J, Majdic O, Pickl WF, Rosenkranz A, Prager E, Gschwantler E, Knapp W: Granulocyte activation via a binding site near the C-terminal region of complement receptor type 3 α-chain (CD11b) potentially involved in intramembrane complex formation with glycosylphospatidylinositol-anchored FcγRIIIB (CD16) molecules. J Immunol 154:5452, 1995
20. Kushner BH, Cheung HKV: GM-CSF enhances 3F8 monoclonal-dependent cellular cytotoxicity against human melanoma and neuroblastoma. Blood 73:1936, 1989
21. Ragnhammar P, Frödin JE, Trotta PP, Mellestedt H: Cytotoxicity of white blood cells activated by granulocyte-colony-stimulating factor, granulocyte-macrophage-colony-stimulating factor and macrophage-colony-stimulating factor against tumor cells in the presence of various monoclonal antibodies. Cancer Immunol Immunother 39:254, 1994
22. Dallegri F, Patrone F, Holm G, Garthon G, Sacchetti C: Neutrophil-mediated antibody-dependent cellular cytotoxicity against erythrocytes. Mechanisms of target cell destruction. Clin Exp Immunol 52:613, 1983
23. Colotta F, Re F, Polentarutti N, Sozzani S, Mantovani A: Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood 80:2012, 1992
24. Flesh BK, Achtert G, Neppert J: Inhibition of monocyte and polymorphonuclear granulocyte immune phagocytosis by monoclonal antibodies specific for FcgRI, II and III. Ann Hematol 74:15, 1977
25. Graziano RF, Fanger MW: FcgRI and FcγRII on monocytes and granulocytes are cytotoxic trigger molecules for tumor cells. J Immunol 139:3536, 1987
26. Petty HR, Francis JW, Anderson CL: Cell surface distribution of Fc receptors II and III on living human neutrophils before and during antibody-dependent cellular cytotoxicity. J Cell Physiol 141:598, 1989
27. Kishimoto TK, Anderson DC: The role of integrins in inflammation, in Gallin JI, Goldstein IM, Snyderman R (eds): Inflammation: Basic Principles and Clinical Correlates. New York, NY, Raven, 1992, p 353
28. Kuijpers TW, Hoogerwerf M, van der Laan LJW, Nagel G, van der School CE, Grunert F, Roos D: CD66 nonspecific cross-reacting antigens are involved in neutrophil adherence to cytokine-activated endothelial cells. J Cell Biol 118:457, 1992
29. Ruchaud-Sparagano MH, Stocks SC, Turley H, Dransfield I: Activation of neutrophil function via CD66: Differential effects upon β2 integrin mediated adhesion. Br J Haematol 98:612, 1997
30. Diamond MS, Springer TA: A subpopulation of Mac-1 (CD11b/ CD18) molecules mediates neutrophil adhesion to ICAM-1 and fibrinogen. J Cell Biol 120:545, 1993